Peter I. Tattersall, PhD (he/him/his)

Director
Analytical Strategy & Operations / Bristol Myers Squibb
New Brunswick, New Jersey

Peter Tattersall, Ph.D. is a Director in Analytical and Bioanalytical Development department within Pharmaceutical Development at Bristol-Myers Squibb Company in New Jersey. He received his BSc. and Ph.D. from the University of Manchester, UK. He previously worked in Analytical Development at AstraZeneca, Wilmington. He joined Bristol-Myers Squibb in 2003 where he is an analytical team leader within Chemical and Synthetic Development. He supervises a group of analytical chemists supporting small molecule synthesis development and who work on method development, validation and transfer in support of clinical and commercial (PPQ) supply of drug substance

Disclosure information not submitted.

Presentation(s):

• Lessons Learned from Registrational Analytical Methods Transfer and Validation at External CMOs in Support of Drug Substance Processes

  Thursday, July 25, 2024
  9:35 AM – 10:05 AM CST

• Joint Session: Panel Discussion

  Thursday, July 25, 2024
  10:05 AM – 10:35 AM CST